Dacomitinib‐induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats-Reference-Cited by-同舟云学术

Dacomitinib‐induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats

Published:2017-03-28 Issue:12 Volume:140 Page:2820-2829
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Van Sebille Ysabella Z.A.¹^ORCID,Gibson Rachel J.¹²,Wardill Hannah R.¹,Secombe Kate R.¹,Ball Imogen A.¹,Keefe Dorothy M.K.¹,Finnie John W.³,Bowen Joanne M.¹

Affiliation:

1. Cancer Treatment Toxicities Group, Adelaide Medical School, University of AdelaideAdelaide Australia

2. Division of Health SciencesUniversity of South AustraliaAdelaide Australia

3. SA Pathology, Research DivisionAdelaide Australia

Funder

Pfizer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30699

Reference34 articles.

1. A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck

2. Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology;Dietrich E;Hippokratia,2012

3. The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib

4. Untangling the ErbB signalling network

5. Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib‐induced diarrhea in HER2‐positive breast cancer—A pilot study;Physiological Reports;2024-08

2. Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors;Heliyon;2024-03

3. Localization of Sites of Osimertinib Action in Rat Intestine, Skin, and Lung by Immunohistochemistry;ACTA HISTOCHEMICA ET CYTOCHEMICA;2023-12-28

4. Lapatinib-induced ErbB1 Inhibition Modulates Caco-2 Intestinal Permeability Through Tight Junction Alteration;2023-11-03

5. Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats;Neoplasia;2023-09